JP2013539772A - 非澱粉を基にしたソフトチュアブル - Google Patents

非澱粉を基にしたソフトチュアブル Download PDF

Info

Publication number
JP2013539772A
JP2013539772A JP2013533180A JP2013533180A JP2013539772A JP 2013539772 A JP2013539772 A JP 2013539772A JP 2013533180 A JP2013533180 A JP 2013533180A JP 2013533180 A JP2013533180 A JP 2013533180A JP 2013539772 A JP2013539772 A JP 2013539772A
Authority
JP
Japan
Prior art keywords
soft chewable
soft
chewable
disintegrant
active ingredient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013533180A
Other languages
English (en)
Japanese (ja)
Inventor
カニカンティ・ベンカタ−ランガラオ
ハンス−ユルゲン・ハマン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Intellectual Property GmbH
Original Assignee
Bayer Intellectual Property GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Intellectual Property GmbH filed Critical Bayer Intellectual Property GmbH
Publication of JP2013539772A publication Critical patent/JP2013539772A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Confectionery (AREA)
JP2013533180A 2010-10-12 2011-10-11 非澱粉を基にしたソフトチュアブル Pending JP2013539772A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39215010P 2010-10-12 2010-10-12
US61/392,150 2010-10-12
PCT/EP2011/067699 WO2012049156A1 (en) 2010-10-12 2011-10-11 Non-starch based soft chewables

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016099504A Division JP6200548B2 (ja) 2010-10-12 2016-05-18 非澱粉を基にしたソフトチュアブル

Publications (1)

Publication Number Publication Date
JP2013539772A true JP2013539772A (ja) 2013-10-28

Family

ID=45065865

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2013533180A Pending JP2013539772A (ja) 2010-10-12 2011-10-11 非澱粉を基にしたソフトチュアブル
JP2016099504A Expired - Fee Related JP6200548B2 (ja) 2010-10-12 2016-05-18 非澱粉を基にしたソフトチュアブル

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016099504A Expired - Fee Related JP6200548B2 (ja) 2010-10-12 2016-05-18 非澱粉を基にしたソフトチュアブル

Country Status (11)

Country Link
US (1) US9744127B2 (enExample)
EP (1) EP2627314B1 (enExample)
JP (2) JP2013539772A (enExample)
CN (1) CN103200930A (enExample)
AU (1) AU2011315555B2 (enExample)
BR (1) BR112013008834B1 (enExample)
CA (1) CA2814082A1 (enExample)
ES (1) ES2806256T3 (enExample)
MX (1) MX2013003684A (enExample)
RU (1) RU2627420C2 (enExample)
WO (1) WO2012049156A1 (enExample)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020528919A (ja) * 2017-07-26 2020-10-01 ティージーエックス ソフト チュー エルエルシー 獣医用途のためのデンプン不含のソフトチュー
JP2020531428A (ja) * 2017-08-17 2020-11-05 セバ・サンテ・アニマル 経口用組成物及びその調製方法
JP2022546241A (ja) * 2019-09-06 2022-11-04 エランコ・ユーエス・インコーポレイテッド 嗜好性ソフトチュー
JP2023517906A (ja) * 2020-03-09 2023-04-27 バイエル・アニマル・ヘルス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 動物への投与のための軟咀嚼剤成形体

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2012307656B2 (en) 2011-09-15 2016-07-07 Friulchem Spa Compositions for oral administration to animals, production methods thereof and uses of same
AP2014007874A0 (en) 2012-02-06 2014-08-31 Merial Ltd Parasiticidal oral veterinary compositions comprising systemetically- acting active agents, methods and uses thereof
CN108685894B (zh) * 2012-04-04 2022-04-26 英特维特国际股份有限公司 软咀嚼药用产品
CA2883139C (fr) 2012-08-31 2021-08-10 Friulchem Spa Compositions pour administration orale aux animaux, leurs procedes d'obtention et leurs utilisations
AU2013361760B2 (en) * 2012-12-19 2018-07-05 Elanco Animal Health Gmbh Tablets with improved acceptance and good storage stability
US9808010B2 (en) * 2015-07-06 2017-11-07 Virbac Corporation Chewable composition
JP2019502776A (ja) 2015-11-20 2019-01-31 アイエスピー インヴェストメンツ エルエルシー ラクタム部分を有する増殖性ポリマー
JP2019514991A (ja) 2016-05-12 2019-06-06 バイエル・アニマル・ヘルス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＢａｙｅｒ Ａｎｉｍａｌ Ｈｅａｌｔｈ Ｇｍｂｈ 動物に投与するための成型体の製造方法
KR102941104B1 (ko) * 2020-05-06 2026-03-19 마아즈, 인코오포레이티드 의약품의 투여를 위한 기호성 지지 조성물
AU2021335500A1 (en) 2020-09-04 2023-05-04 Elanco Us Inc. Palatable formulations
FR3138315A1 (fr) 2022-07-27 2024-02-02 Virbac Produit à usage vétérinaire et procédé pour sa fabrication
PE20231574A1 (es) * 2023-02-24 2023-10-04 Agrovet Market S A Composicion farmaceutica que comprende fluralaner, moxidectina y praziquantel para el tratamiento de infestaciones parasitarias en animales menores

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006502140A (ja) * 2002-08-16 2006-01-19 メリアル リミテッド 非動物製品含有獣医製剤
JP2007516285A (ja) * 2003-12-23 2007-06-21 メリアル リミテッド 非動物産物含有動物用製剤
US20080160067A1 (en) * 2006-09-07 2008-07-03 Albert Boeckh Novel soft chewable, tablet, and long-acting injectable veterinary antibiotic formulations

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5746986A (en) 1980-09-02 1982-03-17 Dai Ichi Seiyaku Co Ltd Pyrido(1,2,3-de)(1,4)benzoxazine derivative
US4670444B1 (en) 1980-09-03 1999-02-09 Bayer Ag and-naphthyridine-3-carboxylic acids and antibacte7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-quinoline-rial agents containing these compounds
US4472405A (en) 1982-11-12 1984-09-18 Riker Laboratories, Inc. Antimicrobial 6,7-dihydro-5,8-dimethyl-9 fluoro-1-oxo-1H, 5H-benzo (ij) quinolizine-2-carboxylic acid and derivatives
US4730000A (en) 1984-04-09 1988-03-08 Abbott Laboratories Quinoline antibacterial compounds
AT392789B (de) 1985-01-23 1991-06-10 Toyama Chemical Co Ltd Verfahren zur herstellung von 1-substituierten aryl-1,4-dihydro-4-oxonaphthyridinderivaten
IN166416B (enExample) 1985-09-18 1990-05-05 Pfizer
JPH0479844A (ja) * 1990-07-20 1992-03-13 Ajinomoto Co Inc 反芻動物用飼料添加剤
GB9224855D0 (en) * 1992-11-27 1993-01-13 Smithkline Beecham Plc Pharmaceutical compositions
FR2710637B1 (fr) 1993-09-28 1995-12-08 Roquette Freres Mannitol pulvérulent de friabilité modérée et son procédé de préparation.
GB9508443D0 (en) 1995-04-26 1995-06-14 Gilbertson & Page Biscuit for working racing or sporting dogs
DE19520275A1 (de) 1995-06-02 1996-12-05 Bayer Ag Endoparasitizide Mittel
US5904937A (en) * 1997-10-03 1999-05-18 Fmc Corporation Taste masked pharmaceutical compositions
DE10031044A1 (de) 2000-06-26 2002-01-03 Bayer Ag Endoparasitizide Mittel zur freiwilligen oralen Aufnahme durch Tiere
WO2004014143A1 (en) 2002-08-13 2004-02-19 Akzo Nobel Compositions and process for delivering an additive
US9561182B2 (en) 2003-08-22 2017-02-07 Cure Pharmaceutical Corporation Edible films for administration of medicaments to animals, methods for their manufacture and methods for their use for the treatment of animals
US20060233873A1 (en) 2003-01-24 2006-10-19 Julien Meissonnier Dispersion of taste masked crystals or granules of active substances, chewable soft capsules filled with said dispersion, and process for preparing same
AU2004251439B2 (en) * 2003-06-25 2008-09-11 Novartis Ag Tablet comprising fluvastatin and carmellose calcium
AR045142A1 (es) 2003-07-30 2005-10-19 Novartis Ag Composicion veterinaria masticable ductil de buen sabor
US20070128251A1 (en) 2005-12-07 2007-06-07 Piedmont Pharmaceuticals, Inc. Process for manufacturing chewable dosage forms for drug delivery and products thereof
US7955632B2 (en) * 2005-12-07 2011-06-07 Bayer B.V. Process for manufacturing chewable dosage forms for drug delivery and products thereof
AU2008247327B2 (en) * 2007-05-07 2013-08-22 Jurox Pty Ltd Improved dosage form and process

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006502140A (ja) * 2002-08-16 2006-01-19 メリアル リミテッド 非動物製品含有獣医製剤
JP2007516285A (ja) * 2003-12-23 2007-06-21 メリアル リミテッド 非動物産物含有動物用製剤
US20080160067A1 (en) * 2006-09-07 2008-07-03 Albert Boeckh Novel soft chewable, tablet, and long-acting injectable veterinary antibiotic formulations

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020528919A (ja) * 2017-07-26 2020-10-01 ティージーエックス ソフト チュー エルエルシー 獣医用途のためのデンプン不含のソフトチュー
JP7223744B2 (ja) 2017-07-26 2023-02-16 ティージーエックス ソフト チュー エルエルシー 獣医用途のためのデンプン不含のソフトチュー
JP2020531428A (ja) * 2017-08-17 2020-11-05 セバ・サンテ・アニマル 経口用組成物及びその調製方法
JP7412329B2 (ja) 2017-08-17 2024-01-12 セバ・サンテ・アニマル 経口用組成物及びその調製方法
JP2022546241A (ja) * 2019-09-06 2022-11-04 エランコ・ユーエス・インコーポレイテッド 嗜好性ソフトチュー
JP2023517906A (ja) * 2020-03-09 2023-04-27 バイエル・アニマル・ヘルス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 動物への投与のための軟咀嚼剤成形体
JP7792342B2 (ja) 2020-03-09 2025-12-25 エランコ アニマル ヘルス ゲー・エム・ベー・ハー 動物への投与のための軟咀嚼剤成形体

Also Published As

Publication number Publication date
BR112013008834A2 (pt) 2016-06-28
CA2814082A1 (en) 2012-04-19
CN103200930A (zh) 2013-07-10
RU2013120907A (ru) 2014-11-20
JP6200548B2 (ja) 2017-09-20
EP2627314A1 (en) 2013-08-21
BR112013008834B1 (pt) 2021-08-03
RU2627420C2 (ru) 2017-08-08
AU2011315555B2 (en) 2016-03-10
WO2012049156A1 (en) 2012-04-19
AU2011315555A1 (en) 2013-05-02
EP2627314B1 (en) 2020-05-06
JP2016175936A (ja) 2016-10-06
US20130197006A1 (en) 2013-08-01
US9744127B2 (en) 2017-08-29
ES2806256T3 (es) 2021-02-17
MX2013003684A (es) 2013-05-31

Similar Documents

Publication Publication Date Title
JP6200548B2 (ja) 非澱粉を基にしたソフトチュアブル
US20120046296A1 (en) Palatable ductile chewable veterinary composition
US11147764B2 (en) Tablets with improved acceptance and good storage stability
WO2004016252A1 (en) Non-animal product containing veterinary formulations
TW202122077A (zh) 適口軟咀嚼物
US20210068425A1 (en) Palatable granular veterinary compositions
US20190110985A1 (en) Process for preparing shaped articles for administration to animals
RU2799052C1 (ru) Таблетки с улучшенным приёмом и хорошей устойчивостью при хранении
HK1186983A (en) Non-starch based soft chewables
HK40079612A (en) Palatable soft-chew

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20141008

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20150202

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20150602

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20150625

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20150714

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20151014

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20160119